LABORATORY NEWS
-
Gold Standard Diagnostics, A Eurofins Technologies Company, Announces A PCR Assay For The Detection Of The Monkeypox And Orthopox Virus
Gold Standard Diagnostics Europe continues its response to the threat of emerging infectious diseases by developing a new multiplex Real-time PCR assay for the detection of the monkeypox virus and its differentiation from other orthopox viruses.
- Fluent BioSciences Launches Industry's Most Accessible, Cost-Effective And Scalable Technology (PIPseqTM) To Accelerate Adoption Of Single-Cell RNA Sequencing In Any Laboratory
- Nucleix Expands EU Label Indication Of Bladder EpiCheck To Include The Detection Of Primary Bladder Cancer And Detection Of Primary And Recurrent Upper Tract Urinary Cancer
- HHS Expanding Monkeypox Testing Capacity To Five Commercial Laboratory Companies
- Illumina Launches Research Test Codeveloped With Merck To Unlock Deeper Insights Into The Tumor Genome
ARCHIVED NEWSLETTER
- 06.28.22 -- wNMR: Spectroscopy From Biomanufacturing To Point-Of-Care
- 06.14.22 -- New ICH Q14 Guidance Applies QbD To Analytical Procedures
- 06.08.22 -- New Episodes for You: Live Biologics & The Microbiome, Inside CAR-T Therapy for Ovarian Cancer and more.
- 05.24.22 -- FDA Seeks Public Comment On Quality Metrics Reporting Program
- 05.10.22 -- The Clinical Trial Sponsor's Roadmap To Avoid EMA (Cyber) Perdition
This website uses cookies to ensure you get the best experience on our website. Learn more